Our Solutions

Newsletters

NEWSLETTERS

  • Newsletter

    May 2015

    May 1, 2015

    We are proud to have partnered with Cognitive Research Corporation to evaluate the sedation-related safety of Flibanserin in premenopausal women. A research study sponsored by Sprout Pharmaceuticals.

  • Newsletter

    April 2015

    Apr 1, 2015

    We now have the ability to play a key role in the evolution of CDISC standards. As a CDISC Gold member Algorithme Phama can further collaborate with global leaders and contribute toward the development and release of new standards.

  • Newsletter

    February 2015

    Feb 1, 2015

    Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contract being signed, and despite the holiday hustle.

  • Newsletter

    January 2015

    Jan 1, 2015

    The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.

  • Newsletter

    Vince & Associates Clinical Research - Newsletter January 2015

    Jan 1, 2015

    Vince & Associates’ Stellar Regulatory History, Pharmacology Unit Expansion, Joins The Cardiac Safety Research Consortium, Qualified as Early Phase Provider for Clinical Evaluation of Thorough QT and Upcoming Presentations.

  • Newsletter

    November 2014

    Nov 1, 2014

    The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations, Thank you to everyone who joined us at the AAPS Annual Meeting in San Diego and Don't miss the 7th EBF Open Symposium!

  • Newsletter

    October 2014

    Oct 1, 2014

    Development and Validation of an ELISA for the Determination of AB-16B5 in Rat Serum, AAPS Annual Meeting, San Diego, Webinar — Impaired Renal Function Clinical Trials: Early Phase Planning to Minimize Risks and Accelerate Drug Development and 7th Open Symposium of EBF.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.